<< Back

NS5A Inhibitors

NS5A is an HCV protein, a part of the HCV replication complex (replicase), with multiple functions in the virus's life cycle. Daklinza is used in combination with Sovaldi as a component of interferon- and ribavirin-free regimens.

*generic or biosimilar available

E experimental

	DRUG	GENERIC NAME	COMPANY
	Daklinza	daclatasvir	Bristol-Myers Squibb

DRUG Daklinza

GENERIC NAME daclatasvir
COMPANY Bristol-Myers Squibb

Last Reviewed: March 5, 2019

NS5A Inhibitors

Hot topics

Forums: Support and discussion

Blogs: The community speaks

Hep Stories: Get inspired

Magazine: Search the archives

#Coffee

#BabyBoomers